TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 8 | 7 | 4 | 6 | 23 | 38 | 14 |
| P | %wins | 100 | 100 | 67 | 33 | 67 | 67 | 72 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/14 20:57 | 2/28/14 | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Frost Gregory Ian | MD | O | SVP--Hea | P.m | 2,595 | 25.95 | 17 | 100 | New | 100 | D | 12 | 13 | -33 | -16 | -6 | -6 | 11 | 6 | -1 | -15 | -23 | 90 | ||
8/14/12 20:17 | 8/13/12 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Frost Gregory Ian | CA | DO | CEO,P | P | 11 | 5.50 | 11 | 2 | 0 | 3,555 | D | -17 | -12 | -50 | -22 | -41 | -34 | 31 | -6 | 8 | 6 | 7 | -7 | 5 | 24 |
8/10/11 20:29 | 8/9/11 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Frost Gregory Ian | CA | DO | CEO,P | P | 35 | 5.84 | 3 | 6 | 0 | 3,537 | D | -19 | -17 | -15 | -9 | -13 | -15 | -12 | 5 | 4 | 9 | 6 | 39 | 86 | -1 |
8/23/05 13:57 | 8/23/05 | HTI | Halozyme Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Frost Gregory Ian | CA | DO | VP,Chief | P | 8 | 1.69 | 0 | 5 | 0 | 3,064 | D | ||||||||||||||
8/18/04 19:43 | 8/18/04 | HZYM | Halozyme Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Frost Gregory Ian | CA | DO | VP,Chief | P | 8 | 1.65 | 0 | 5 | 0 | 2,959 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |